{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:37:55Z","timestamp":1788907075708,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cytological screening remains a high-impact practice, particularly in low-resource settings, for preventing cervical cancer. The examination of screening practices over time and the prevalence of epithelial abnormalities have not been investigated in longitudinal studies in one of the largest countries in the Middle East and Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Routine healthcare data, between March 1981 and December 2022, were extracted from the database of the Early Cancer Detection Unit in a tertiary referral university hospital in the Greater Cairo Region, Egypt. Cervical smears were obtained using a standardized technique and sent to the cytopathology laboratory for conventional cytology examination by expert pathologists. The anonymous data were analyzed to determine the temporal trend of the number of women screened each year and the prevalence of epithelial abnormalities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Data included the results of satisfactory smears from 95120 women. The mean age (SD) of the women at the time of screening was 38.5 (10.5). None of the included women received an HPV vaccine. Abnormal epithelial cells were reported in 5174 women (5.44%). Of these epithelial abnormalities, the majority were low-grade squamous intraepithelial lesions in 4144 women (4.36%). Other abnormalities included atypical squamous cells in 378 women (0.40%), high-grade squamous intraepithelial lesions in 226 women (0.24%), atypical glandular cells not otherwise specified in 184 women (0.19%), adenocarcinoma in 165 women (0.17%), squamous cell carcinoma in 70 women (0.07%), and atypical glandular cells favoring neoplasms in 7 women (0.01%). Women who were at an early age at first intercourse, those who opted for routine cervical cytology screening, and those who were older at screening were more likely to have epithelial abnormalities. The yearly number of screened women was positively associated with the detection of low-grade squamous intraepithelial lesions (correlation coefficient [95% CI]\u2009=\u20090.84 [0.72, 0.91]) and negatively associated with the detection of squamous cell carcinoma (correlation coefficient [95% CI]\u2009=\u2009-0.55 [-0.73, -0.29]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The small number of annually screened Egyptian women and the temporal trend in epithelial abnormalities critically demonstrate the need for establishing and scaling up a structured population-based program to achieve the goal of eliminating cervical cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-024-03254-1","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T07:03:13Z","timestamp":1721199793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cervical cancer screening by cytology and the burden of epithelial abnormalities in low resource settings: a tertiary-center 42-year study"],"prefix":"10.1186","volume":"24","author":[{"given":"Sahar","family":"Ezzelarab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amro","family":"El-Husseiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Nasreldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwa","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4572-2210","authenticated-orcid":false,"given":"Ashraf","family":"Nabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Early Cervical Cancer Detection Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Abdel-Razek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Abdel-Salam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Abdel-Salam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Alloub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdy","family":"Alqenawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Alshabrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohair","family":"Ayaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"El-Sallaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mortada","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragia","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa","family":"Kasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Moubarak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Morsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragaa","family":"Rifaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Sakna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Shehabeldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Zenhom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"key":"3254_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149:778\u201389.","journal-title":"Int J Cancer"},{"key":"3254_CR2","doi-asserted-by":"publisher","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","volume":"2","author":"M Schiffman","year":"2016","unstructured":"Schiffman M, Doorbar J, Wentzensen N, de Sanjos\u00e9 S, Fakhry C, Monk BJ, et al. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers. 2016;2:16086.","journal-title":"Nat Rev Dis Primers"},{"key":"3254_CR3","unstructured":"Wright J. Cervical intraepithelial neoplasia: Terminology, incidence, pathogenesis, and prevention. In: Goff B, editor. UpToDate. Wolters Kluwer.\u00a0Available from https:\/\/www.uptodate.com\/contents\/cervical-intraepithelial-neoplasia-terminology-incidence-pathogenesis-and-prevention. Accessed 8 Mar 2024."},{"key":"3254_CR4","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1056\/NEJMsr2030640","volume":"385","author":"V Bouvard","year":"2021","unstructured":"Bouvard V, Wentzensen N, Mackie A, Berkhof J, Brotherton J, Giorgi-Rossi P, et al. The IARC perspective on cervical cancer screening. N Engl J Med. 2021;385:1908\u201318.","journal-title":"N Engl J Med"},{"key":"3254_CR5","unstructured":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. Second edition. Geneva: World Health Organization; 2021. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK572317\/. Accessed 8 Mar 2024."},{"key":"3254_CR6","volume-title":"Global strategy to accelerate the elimination of cervical cancer as a public health problem","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020."},{"key":"3254_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050132","volume":"5","author":"E Gakidou","year":"2008","unstructured":"Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: Low average levels and large inequalities. PLoS Med. 2008;5:e132.","journal-title":"PLoS Med"},{"key":"3254_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/2046-4053-2-35","volume":"2","author":"L Peirson","year":"2013","unstructured":"Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R. Screening for cervical cancer: A systematic review and meta-analysis. Syst Rev. 2013;2:35.","journal-title":"Syst Rev"},{"key":"3254_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jama.2023.13174","volume":"330","author":"RB Perkins","year":"2023","unstructured":"Perkins RB, Wentzensen N, Guido RS, Schiffman M. Cervical cancer screening: A review. JAMA, J Am Med Assoc. 2023;330:547.","journal-title":"JAMA, J Am Med Assoc"},{"key":"3254_CR10","unstructured":"Ministry of Health and Population, El-Zanaty and Associates, ICF International. Egypt Health Issues Survey 2015. Cairo and Rockville; 2015. Available from https:\/\/dhsprogram.com\/pubs\/pdf\/FR313\/FR313.pdf. Accessed\u00a08 Mar 2024."},{"key":"3254_CR11","doi-asserted-by":"publisher","first-page":"101813","DOI":"10.1016\/j.pmedr.2022.101813","volume":"28","author":"W Wang","year":"2022","unstructured":"Wang W, Arc\u00e0 E, Sinha A, Hartl K, Houwing N, Kothari S. Cervical cancer screening guidelines and screening practices in 11 countries: A systematic literature review. Preventive Medicine Reports. 2022;28:101813.","journal-title":"Preventive Medicine Reports"},{"issue":"649","key":"3254_CR12","first-page":"e1","volume":"225","author":"H Hosier","year":"2021","unstructured":"Hosier H, Sheth SS, Oliveira CR, Perley LE, Vash-Margita A. Unindicated cervical cancer screening in adolescent females within a large healthcare system in the United States. Am J Obstet Gynecol. 2021;225(649):e1\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"3254_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.15537\/smj.2015.1.9141","volume":"36","author":"HM Al-Kadri","year":"2015","unstructured":"Al-Kadri HM, Kamal M, Bamuhair SS, Omair AA, Bamefleh HS. Prevalence and characteristics of abnormal Papanicolaou smear in Central Saudi Arabia. Saudi Med J. 2015;36:117\u201322.","journal-title":"Saudi Med J"},{"key":"3254_CR14","first-page":"3117","volume":"18","author":"B Maraqa","year":"2017","unstructured":"Maraqa B, Lataifeh I, Ottai L, Badran O, Nouri YQ, Issam I, et al. Prevalence of abnormal pap smears: A descriptive study from a cancer center in a low-prevalence community. Asian Pac J Cancer Prev. 2017;18:3117\u201321.","journal-title":"Asian Pac J Cancer Prev"},{"key":"3254_CR15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.12816\/0003173","volume":"12","author":"GJ Al Eyd","year":"2012","unstructured":"Al Eyd GJ, Shaik RB. Rate of opportunistic pap smear screening and patterns of epithelial cell abnormalities in pap smears among women attending a teaching hospital in ajman, united arab emirates. Sultan Qaboos Univ Med J. 2012;12:473\u20138.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"3254_CR16","first-page":"e112","volume":"15","author":"K Kapila","year":"2015","unstructured":"Kapila K, Sharma PN, George SS, Al-Shaheen A, Al-Juwaiser A, Al-Awadhi R. Trends in epithelial cell abnormalities observed on cervical smears over a 21-Year period in a tertiary care hospital in kuwait. Sultan Qaboos Univ Med J. 2015;15:e112\u2013115.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"3254_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4103\/JOC.JOC_199_15","volume":"34","author":"A Akinfolarin","year":"2017","unstructured":"Akinfolarin A, Olusegun A, Omoladun O, Omoniyi-Esan G, Onwundiegu U. Age and pattern of Pap smear abnormalities: Implications for cervical cancer control in a developing country. Journal of Cytology. 2017;34:208.","journal-title":"Journal of Cytology"},{"key":"3254_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12907-015-0016-2","volume":"15","author":"M Getinet","year":"2015","unstructured":"Getinet M, Gelaw B, Sisay A, Mahmoud EA, Assefa A. Prevalence and predictors of Pap smear cervical epithelial cell abnormality among HIV-positive and negative women attending gynecological examination in cervical cancer screening center at Debre Markos referral hospital, East Gojjam. Northwest Ethiopia BMC Clinical Pathology. 2015;15:16.","journal-title":"Northwest Ethiopia BMC Clinical Pathology"},{"key":"3254_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ejogrb.2006.07.022","volume":"134","author":"S Gupta","year":"2007","unstructured":"Gupta S, Sodhani P, Halder K, Chachra KL, Sardana S, Singh V, et al. Spectrum of epithelial cell abnormalities of uterine cervix in a cervical cancer screening programme: Implications for resource limited settings. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2007;134:238\u201342.","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"3254_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3322\/caac.21628","volume":"70","author":"ETH Fontham","year":"2020","unstructured":"Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA A Cancer J Clin. 2020;70:321\u201346.","journal-title":"CA A Cancer J Clin"},{"key":"3254_CR21","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1089\/jwh.2011.3385","volume":"21","author":"O Adegoke","year":"2012","unstructured":"Adegoke O, Kulasingam S, Virnig B. Cervical cancer trends in the united states: A 35-Year population-based analysis. Journal of Women\u2019s Health. 2012;21:1031\u20137.","journal-title":"Journal of Women\u2019s Health"},{"key":"3254_CR22","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1038\/s41598-018-23947-6","volume":"8","author":"Y Ueda","year":"2018","unstructured":"Ueda Y, Yagi A, Nakayama T, Hirai K, Ikeda S, Sekine M, et al. Dynamic changes in Japan\u2019s prevalence of abnormal findings in cervical cytology depending on birth year. Sci Rep. 2018;8:5612.","journal-title":"Sci Rep"},{"key":"3254_CR23","doi-asserted-by":"publisher","first-page":"e026292","DOI":"10.1136\/bmjopen-2018-026292","volume":"9","author":"F Pesola","year":"2019","unstructured":"Pesola F, Sasieni P. Impact of screening on cervical cancer incidence in England: A time trend analysis. BMJ Open. 2019;9:e026292.","journal-title":"BMJ Open"},{"key":"3254_CR24","doi-asserted-by":"publisher","first-page":"e0238291","DOI":"10.1371\/journal.pone.0238291","volume":"15","author":"AS Chauhan","year":"2020","unstructured":"Chauhan AS, Prinja S, Srinivasan R, Rai B, Malliga J, Jyani G, et al. Cost effectiveness of strategies for cervical cancer prevention in India. PLoS ONE. 2020;15:e0238291.","journal-title":"PLoS ONE"},{"key":"3254_CR25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12905-022-02043-y","volume":"22","author":"Z Petersen","year":"2022","unstructured":"Petersen Z, Jaca A, Ginindza TG, Maseko G, Takatshana S, Ndlovu P, et al. Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: A systematic review. BMC women\u2019s health. 2022;22:486.","journal-title":"BMC women\u2019s health"},{"key":"3254_CR26","doi-asserted-by":"publisher","unstructured":"Golia D\u2019Aug\u00e8 T, Cuccu I, Etrusco A, D\u2019Amato A, Lagan\u00e0 AS, D\u2019Oria O, et al. State of the art on HPV-related cervical lesions. Italian J Gynaecol Obstet. 2024;36(02):135. Available from: https:\/\/doi.org\/10.36129\/jog.2024.161.","DOI":"10.36129\/jog.2024.161"},{"issue":"2","key":"3254_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/03008916231208344","volume":"110","author":"G Bogani","year":"2024","unstructured":"Bogani G, Sopracordevole F, Ciavattini A, Ghelardi A, Vizza E, Vercellini P, et al. HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: A focus on the potential role of vaccination. Tumori Journal. 2024;110(2):139\u201345.","journal-title":"Tumori Journal"},{"issue":"1","key":"3254_CR28","doi-asserted-by":"publisher","first-page":"20230826","DOI":"10.1515\/med-2023-0826","volume":"18","author":"A Despot","year":"2023","unstructured":"Despot A, Fure\u0161 R, Despot A, Miku\u0161 M, Zlopa\u0161a G, D\u2019Amato A, Chiantera V, Serra P, Etrusco A, Lagan\u00e0 A. Reactive oxygen species within the vaginal space: An additional promoter of cervical intraepithelial neoplasia and uterine cervical cancer development? Open Medicine. 2023;18(1):20230826.","journal-title":"Open Medicine"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-024-03254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-024-03254-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-024-03254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T07:03:22Z","timestamp":1721199802000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-024-03254-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3254"],"URL":"https:\/\/doi.org\/10.1186\/s12905-024-03254-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4078436\/v1","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]},"assertion":[{"value":"11 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by the Institutional Review Board of the Department of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt. All research was performed in accordance with relevant guidelines. A waiver for informed consent to participate was approved by the Institutional Review Board of the Faculty of Medicine, Ain Shams University, Egypt (assurance no. FWA00017585) because this retrospective chart review involves no more than minimal risk, the research could not practicably be carried out without the waiver, and the waiver would not adversely affect the rights and welfare of the subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"405"}}